American Portfolios Advisors’s Cymabay Therapeutics CBAY Stock Holding History

American Portfolios Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-350	Closed	-$1.59K	–	3467
2021 Q1	$1.59K	Hold	350	–	–	﹤0.01%	3047
2020 Q4	$2.01K	Hold	350	–	–	﹤0.01%	2703
2020 Q3	$2.53K	Hold	350	–	–	﹤0.01%	2516
2020 Q2	$1.22K	Hold	350	–	–	﹤0.01%	2654
2020 Q1	$518	Hold	350	–	–	﹤0.01%	2661
2019 Q4	$686	Sell	350 -380	-52%	-$1.43K	﹤0.01%	2726
2019 Q3	$3.74K	Hold	730	–	–	﹤0.01%	2295
2019 Q2	$5.23K	Buy	730 +380	+109%	+$4.3K	﹤0.01%	2169
2019 Q1	$4.65K	Hold	350	–	–	﹤0.01%	2119
2018 Q4	$2.75K	Buy	+350	New	+$3.33K	﹤0.01%	2057

Other funds holding CBAY

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return